Cannabis in Medicine
A primer for health care professionals
Friday February 22, 2013
The objective is to present a balanced and expert overview on the clinical use of cannabinoids to an engaged audience of healthcare practitioners in mainstream hospital-clinical settings.
The lecture series will focus on the clinical and practical therapeutic potential of cannabinoids and the endocannabinoid system.
At the end of the session, participants will be able to:
Online Advance Registration fees:
To register as an MD/DO or Allied HCP/Physician in training you must be engaged in clinical practice and not employed by a pharmaceutical, medical device, medical education/advertising agency. If you are employed by a pharmaceutical, medical device, medical education/advertising agency please register as an Industry Representative.
Note regarding Onsite Registrations: Please arrive at least 15 minutes in advance (by 1:45pm) to allow for your registration to be processed prior to the scheduled session start time.
Cancellations are accepted up to Feb 14 with a $30.00 cancellation fee. No refunds or cancellations after Feb 14, 2013. All cancellation refund requests should be submitted in writing to the UCSF OCME by fax, mail or email (firstname.lastname@example.org).
Registration is being admistered by the University of California San Francisco, Office of Continuing Medical Education. To register and pay the registration fee you will be redirected to the UCSF OCME website. Please click on the following link for the session registration pages:
Washington, DC - Friday February 22, 2013 (UCSF Course Number MMJ13001C)
If you have any questions or concerns regarding your registration or the registration process please contact:
This activity has been planned and implemented in accordance with the essential areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of California, San Francisco School of Medicine (UCSF) and the Canadian Consortium for the Investigation of Cannabinoids (CCIC). UCSF is accredited by the ACCME to provide continuing medical education for physicians.
UCSF designates this educational activity for a maximum of 2.75 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Donald Abrams, MD
Jeffrey Hergenrather, MD
Donald Tashkin, MD
Mark A. Ware, MBBS MRCP MSc
Mayflower Renaissance Hotel, Washington, DC
The post program evaluation will be available as of February 22, 2013. Only session attendees who did not complete an evaluation on site should complete this questionnaire. This anonymous survey will enable attendees to rate various aspects of their session and provide feedback about the content and organization of the activity. Please contact CCIC Education Coordinator, Daniel Ziemianski (email@example.com) to complete your evaluation form if you did not do so onsite.